GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Hercules Capital Inc (NYSE:HTGC) » Definitions » Quality Rank

Hercules Capital (Hercules Capital) Quality Rank


View and export this data going back to 2005. Start your Free Trial

What is Hercules Capital Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Hercules Capital Quality Rank Related Terms

Thank you for viewing the detailed overview of Hercules Capital's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hercules Capital (Hercules Capital) Business Description

Traded in Other Exchanges
Address
400 Hamilton Avenue, Suite 310, Palo Alto, CA, USA, 94301
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Executives
Nikos Theodosopoulos director C/O ARISTA NETWORKS, INC., 5453 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054
Christian Follmann officer: Chief Operating Officer C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Gayle A Crowell director
Wade Loo director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Scott Bluestein officer: Chief Investment Officer 303 COLUMBUS AVENUE, APT 506, BOSTON MA 02116
Deanne Aguirre director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Thomas J Fallon director C/O INFINERA CORPORATION, 140 CASPIAN COURT, SUNNYVALE CA 94089
Kiersten Zaza Botelho officer: General Counsel & CCO C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Paramjeet K Randhawa director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Carol L Foster director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Seth H Meyer officer: Chief Financial Officer C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Jorge Titinger director 7005 SOUTHFRONT ROAD, LIVERMORE CA 94551
Doreen Woo Ho director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Waldt Gerard R Jr. officer: Interim Chief Accounting Off 400 HAMILTON AVENUE SUITE 310, PALO ALTO CA 94301
Bradford C. Koenig director C/O GSV CAPITAL CORP., 2925 WOODSIDE ROAD, WOODSIDE CA 94062